The global Alzheimer’s drugs market size reached US$ 7.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. The rising prevalence of Alzheimer’s disease, numerous advancements in drug development, and increasing public and private funding for neurodegenerative disease research ar... https://www.imarcgroup.com/alzeimers-drugs-market